A randomized controlled trial of eicosapentaenoic acid in patients with coronary heart disease on statins.


BACKGROUND There is a residual risk of coronary heart disease (CHD) despite intensive statin therapy for secondary prevention. The aim of this study was to investigate whether coronary plaque regression and stabilization are reinforced by the addition of eicosapentaenoic acid (EPA) to high-dose pitavastatin (PTV). METHODS We enrolled 193 CHD patients who… (More)
DOI: 10.1016/j.jjcc.2017.07.007


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.